Commercial Price Variation for 11 Outpatient-Based Psychiatric Services
Kyle King, Joshua J. Skydel, Joseph S. Ross, Joshua D. Wallach

TL;DR
This study examines how much prices vary for common outpatient psychiatric services among commercial providers in the US.
Contribution
The study provides new insights into commercial pricing disparities for outpatient psychiatric care.
Findings
Significant price variation was observed across different services and geographic regions.
Commercial prices for psychiatric services often exceeded what is typically covered by insurance.
Abstract
This cross-sectional study evaluates commercial price variation for common outpatient psychiatric services in the US.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Service ( | No. of rates | No. of hospitals | GAF-normalized commercial payer-negotiated rate, $ | Ratio of median rate to Medicare prices | Within-hospital ratio | Between-hospital ratio | ||
|---|---|---|---|---|---|---|---|---|
| Median (IQR) | 10th percentile | 90th percentile | ||||||
| Psychotherapy, 30 min with patient (90832) | 9029 | 1020 | 118 (81-216) | 69 | 379 | 1.08 | 1.15 | 5.45 |
| Psychotherapy, 45 min with patient (90834) | 9054 | 1014 | 170 (112-243) | 96 | 399 | 1.17 | 1.14 | 4.16 |
| Psychotherapy, 60 min with patient (90837) | 8517 | 980 | 223 (155-382) | 134 | 432 | 1.48 | 1.11 | 3.22 |
| Family or couples psychotherapy without the patient present (90846) | 8280 | 920 | 188 (122-271) | 99 | 429 | 1.35 | 1.15 | 4.33 |
| Family or couples psychotherapy with the patient present (90847) | 8727 | 960 | 205 (127-285) | 105 | 432 | 1.45 | 1.15 | 4.11 |
| Group psychotherapy (other than of a multiple-family group) (90853) | 11 540 | 980 | 95 (49-214) | 30 | 250 | 1.51 | 1.16 | 8.33 |
| Psychiatric diagnostic evaluation (without medical services) (90791) | 8741 | 1000 | 216 (161-342) | 141 | 496 | 1.37 | 1.19 | 3.52 |
| Psychiatric diagnostic evaluation with medical services (90792) | 7107 | 916 | 232 (176-374) | 148 | 504 | 1.39 | 1.13 | 3.41 |
| Electroconvulsive therapy (90870) | 7859 | 893 | 532 (249-1021) | 133 | 1593 | 1.31 | 1.18 | 11.98 |
| Transcranial magnetic stimulation treatment, initial (90867) | 7711 | 701 | 476 (316-785) | 297 | 1225 | 1.67 | 1.16 | 4.12 |
| Transcranial magnetic stimulation treatment, subsequent sessions (90868) | 7663 | 694 | 352 (299-707) | 154 | 1201 | 1.21 | 1.12 | 7.80 |
| Commercial payer | Median (IQR) commercial payer-negotiated rate, $ | Commercial payer-negotiated rate, $ | |||
|---|---|---|---|---|---|
| 10th Percentile | 90th Percentile | Difference | |||
|
| |||||
| BCBS | 153 (81-285) | 70 | 438 | 368 | <.001 |
| Cigna | 104 (100-142) | 70 | 271 | 201 | |
| Aetna | 104 (81-158) | 71 | 276 | 205 | |
| UnitedHealthcare | 122 (77-160) | 64 | 259 | 195 | |
|
| |||||
| BCBS | 170 (109-303) | 95 | 474 | 379 | <.001 |
| Cigna | 190 (136-191) | 100 | 297 | 197 | |
| Aetna | 185 (118-205) | 101 | 327 | 226 | |
| UnitedHealthcare | 146 (105-192) | 92 | 307 | 215 | |
|
| |||||
| BCBS | 212 (156-343) | 135 | 474 | 339 | <.001 |
| Cigna | 339 (190-382) | 147 | 382 | 235 | |
| Aetna | 258 (158-382) | 141 | 382 | 241 | |
| UnitedHealthcare | 174 (146-278) | 114 | 384 | 270 | |
|
| |||||
| BCBS | 191 (121-307) | 98 | 474 | 376 | <.001 |
| Cigna | 256 (145-256) | 105 | 309 | 204 | |
| Aetna | 205 (130-307) | 110 | 314 | 204 | |
| UnitedHealthcare | 148 (115-205) | 97 | 319 | 222 | |
|
| |||||
| BCBS | 217 (121-315) | 114 | 309 | 195 | <.001 |
| Cigna | 262 (153-262) | 114 | 309 | 195 | |
| Aetna | 206 (133-262) | 113 | 346 | 233 | |
| UnitedHealthcare | 157 (125-234) | 99 | 354 | 255 | |
|
| |||||
| BCBS | 91 (36-188) | 28 | 296 | 268 | <.001 |
| Cigna | 214 (81-214) | 36 | 214 | 178 | |
| Aetna | 115 (53-214) | 44 | 214 | 170 | |
| UnitedHealthcare | 74 (53-214) | 29 | 210 | 181 | |
|
| |||||
| BCBS | 223 (172-350) | 148 | 510 | 362 | <.001 |
| Cigna | 232 (170-318) | 137 | 443 | 306 | |
| Aetna | 209 (155-342) | 143 | 488 | 345 | |
| UnitedHealthcare | 190 (148-341) | 132 | 501 | 369 | |
|
| |||||
| BCBS | 232 (189-377) | 151 | 488 | 337 | <.001 |
| Cigna | 250 (177-364) | 151 | 586 | 435 | |
| Aetna | 238 (166-379) | 151 | 536 | 385 | |
| UnitedHealthcare | 212 (155-375) | 137 | 504 | 367 | |
|
| |||||
| BCBS | 560 (244-1140) | 131 | 1593 | 1462 | <.001 |
| Cigna | 540 (376-1067) | 161 | 1909 | 1748 | |
| Aetna | 373 (184-540) | 126 | 903 | 777 | |
| UnitedHealthcare | 510 (348-577) | 164 | 1716 | 1552 | |
|
| |||||
| BCBS | 623 (375-933) | 302 | 1325 | 1023 | <.001 |
| Cigna | 501 (316-727) | 316 | 1127 | 811 | |
| Aetna | 316 (312-374) | 284 | 638 | 354 | |
| UnitedHealthcare | 316 (314-629) | 291 | 1462 | 1171 | |
|
| |||||
| BCBS | 484 (247-933) | 90 | 1325 | 1235 | <.001 |
| Cigna | 497 (316-704) | 299 | 1127 | 828 | |
| Aetna | 316 (297-316) | 179 | 527 | 348 | |
| UnitedHealthcare | 316 (302-565) | 280 | 1462 | 1182 | |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Policy and Management · Pharmaceutical Economics and Policy · Global Health Care Issues
Introduction
Prices for outpatient medical services in the US have increased over the past decade^1^ and represent a significant barrier to care, particularly for patients requiring psychiatric services.^2^ Individuals with mental illness are more likely to experience financial insecurity, and nearly one-third report delaying or forgoing treatment due to cost.^3^ Although previous research has identified price variability for numerous hospital-based services,^4,5^ little is known about its extent in psychiatric services. Therefore, we evaluated commercial price variation for common outpatient psychiatric services.
Methods
In this cross-sectional study, we identified prices for 11 commonly billed outpatient psychiatric services using Current Procedural Terminology codes (eMethods in Supplement 1). We searched the Turquoise Health database to identify rates negotiated by the 4 largest US private payers (Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare) for each service as of June 2025, as well as the list, cash, and Medicare prices for hospitals reporting at least 1 commercial payer–negotiated rate (eTable in Supplement 1). This study followed the STROBE reporting guideline; it did not constitute human participant research and was thus exempt from ethics review per the Common Rule.
We adjusted commercial payer–negotiated rates, list prices, and cash prices using the geographic adjustment factor to account for geographic differences and excluded prices outside the 1st and 99th percentiles to reduce outlier effects.^5^ For each service, we calculated the median, IQR, 10th percentile, and 90th percentile of the adjusted commercial payer–negotiated rate and the ratio of median commercial payer–negotiated rate to median list, cash, and Medicare price. We assessed within-hospital variation by calculating the median ratio of the 90th to 10th percentile of commercial payer–negotiated rates within each hospital and between-hospital variation by calculating the ratio of the 90th to 10th percentile of rates across all hospitals. We stratified rates by payer, calculated the median rate and 10th to 90th percentile range within each group, and assessed differences using Kruskal-Wallis tests. Two-tailed P < .05 was considered statistically significant. Analyses were performed using R, version 4.2.3.
Results
We identified 94 228 unique commercial payer-negotiated rates (median per service, 216 [IQR, 155-342]) reported by 1398 hospitals across 49 US states and the District of Columbia. Across all psychiatric services, commercial payer–negotiated rates were a median of 1.37 (IQR, 1.02-1.47) times the Medicare rate, 0.59 (IQR, 0.38-0.85) times the list price, and 1.12 (IQR, 0.87-2.13) times the cash price for the same service. There was variation in commercial payer–negotiated rates both within (median within-hospital ratio, 1.15 [IQR, 1.14-1.16]) and between hospitals (median between-hospital ratio, 4.16 [IQR, 3.82-6.63]) for the same service (Table 1).
Median commercial payer–negotiated rates varied significantly across parent payers for all psychiatric services (Table 2). For 8 of 11 services, the highest median rate was negotiated by Cigna. All insurers showed substantial variation in negotiated rates for services, with Blue Cross Blue Shield having the widest rate range for 6 of 11 codes.
Discussion
This cross-sectional study found wide variation in commercial payer–negotiated rates for 11 hospital-based psychiatric services, with within- and between-hospital price ratios of 1.15 and 4.16, respectively. Although commercial payer–negotiated rates were generally comparable with cash prices and averaged 1.37 times the Medicare rate for the same service, substantial variation was observed across the 4 largest commercial payers, potentially reflecting differences in payer and hospital market shares.^6^ These patterns, consistent with other areas of health care, such as urology and breast cancer,^4,5^ suggest that individuals with the same conditions may encounter different costs for psychiatric services depending on site of care and insurer, which may interact with out-of-pocket costs to influence care-seeking behavior.
Our analyses are limited by inconsistent compliance with price reporting requirements and the resulting uncertainty over whether price variation differs between compliant and noncompliant hospitals, although this risk may be small.^5^ Our analyses cannot determine the reasons for price differences and do not capture nonhospital outpatient psychiatric care. Future research should explore the mechanisms underlying price variation, which may inform future policy decisions.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Price growth by payer—key facts about hospitals. KFF. Accessed July 14, 2025. https://www.kff.org/key-facts-about-hospitals/?entry=hospital-prices-price-growth-by-payer
- 2Spivak S, Cullen B, Eaton WW, Rodriguez K, Mojtabai R. Financial hardship among individuals with serious mental illness. Psychiatry Res. 2019;282:112632. doi:10.1016/j.psychres.2019.112632 31690462 · doi ↗ · pubmed ↗
- 3Moon KJ, Miller KEM, Galea S, Ettman CK. Medical debt and forgone mental health care due to cost among adults. JAMA Health Forum. 2025;6(4):e 250383. doi:10.1001/jamahealthforum.2025.0383 40249609 PMC 12008752 · doi ↗ · pubmed ↗
- 4Gul ZG, Sharbaugh DR, Guercio CJ, . Large variations in the prices of urologic procedures at academic medical centers 1 year after implementation of the Price Transparency Final Rule. JAMA Netw Open. 2023;6(1):e 2249581. doi:10.1001/jamanetworkopen.2022.49581 36602800 PMC 9857154 · doi ↗ · pubmed ↗
- 5Rochlin DH, Rizk NM, Matros E, Wagner TH, Sheckter CC. Commercial price variation for breast reconstruction in the era of price transparency. JAMA Surg. 2023;158(2):152-160. doi:10.1001/jamasurg.2022.6402 36515928 PMC 9856784 · doi ↗ · pubmed ↗
- 6Pathak Y, Muhlestein D. Hospital system market share and commercial prices: a cross-sectional approach using price transparency data. Health Econ Rev. 2024;14(1):102. doi:10.1186/s 13561-024-00580-w 39630317 PMC 11619101 · doi ↗ · pubmed ↗
